Showing results (581-590 of 691) with videos related to
Sort By:
Pageof 70
Journal of Pharmaceutical Sciences|March 21, 2014
A novel strategy for ADME screening of prodrugs: combined use of serum and hepatocytes to integrate bioactivation and clearance, and predict exposure to both active and prodrug to the systemic circulationEdmund Hoppe, Nicola J Hewitt, Hans-Peter Buchstaller, et al.Biology Letters|August 9, 2023
Downsized: gray whales using an alternative foraging ground have smaller morphologyK C Bierlich, A Kane, L Hildebrand, et al.Toxicology and Applied Pharmacology|October 22, 2024
In vitro pharmacologic profiling aids systemic toxicity assessment of chemicalsMatthew Burbank, Predrag Kukic, Gladys Ouedraogo, et al.Frontiers in Pharmacology|January 21, 2022
Use of Physiologically-Based Kinetics Modelling to Reliably Predict Internal Concentrations of the UV Filter, Homosalate, After Repeated Oral and Topical ApplicationAbdulkarim Najjar, Andreas Schepky, Christopher-Tilman Krueger, et al.Journal of Applied Toxicology : JAT|February 17, 2021
Demonstration of the first-pass metabolism in the skin of the hair dye, 4-amino-2-hydroxytoluene, using the Chip2 skin-liver microphysiological modelThi Phuong Tao, Katrin Brandmair, Silke Gerlach, et al.Journal of Thrombosis and Haemostasis : JTH|June 12, 2009
The cost-effectiveness of computer-assisted anticoagulant dosage: results from the European Action on Anticoagulation (EAA) multicentre studyS Jowett, S Bryan, L Poller, et al.Regulatory Toxicology and Pharmacology : RTP|January 6, 2022
A 10-step framework for use of read-across (RAX) in next generation risk assessment (NGRA) for cosmetics safety assessmentCamilla Alexander-White, Dagmar Bury, Mark Cronin, et al.Skin Pharmacology and Physiology|March 20, 2019
Use of a Simple in vitro Test to Assess Loss of Chemical due to Volatility during an in vitro Human Skin Absorption StudySébastien Grégoire, Richard Cubberley, Hélène Duplan, et al.Pain|December 28, 2010
Impact of responder definition on the enriched enrollment randomized withdrawal trial design for establishing proof of concept in neuropathic painDavid J Hewitt, Tony W Ho, Bradley Galer, et al.The Journal of Cell Biology|November 21, 2001
Mice lacking desmocollin 1 show epidermal fragility accompanied by barrier defects and abnormal differentiationM Chidgey, C Brakebusch, E Gustafsson, et al.Pageof 70